Glaucoma Press Releases + Feed Topics Locations Industries Dates
Page updated every 10 minutes
By SMi Conferences
Over the past twelve months there has been significant advancements in cell gene therapy for inherited retinal dystrophy, with an FDA approval of Spark Therapeutics' Voretigene – the first gene therapy approved in ophthalmology.
By Specialty Eye Institute
Specialty Eye Institute will host a 40th Anniversary Celebration on Wednesday, July 18th from 5:30 p.m. – 7:30 p.m. The event will be held at Specialty Eye Institute's Jackson office at 1116 W. Ganson Ave., Jackson, MI 49202, where it all began.
By Coherent Market Insights
Glaucoma Therapeutics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026